Loading
Latest filing published 03 Jun 2025 for Alphamab Oncology - B.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
WEI Kevin Cheng is a declared insider of Alphamab Oncology - B, with filings sourced from HKEX. In total, 2 filings cover trades dated from 23 April 2021 to 29 May 2025.
Purchases make up the whole of the open-market record (2 purchases). No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 1 purchase and no sales.
On 3 June 2025 came the latest disclosure, an open-market purchase in Alphamab Oncology - B. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations